The sweet and sour of cancer: glycans as novel therapeutic targets (Q34439560)

2 August 2017

1 reference

title

The sweet and sour of cancer: glycans as novel therapeutic targets (English)

1 reference

2 August 2017

Mark M Fuster

1

1 reference

2 August 2017

Jeffrey D Esko

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

2 August 2017

Nature Reviews Cancer

1 reference

2 August 2017

5

1 reference

2 August 2017

526-542

1 reference

2 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1649

2 August 2017

0 references

cites work

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc

1 reference

Analysis of differentiation and transformation of cells by lectins

31 March 2020

1 reference

Structural basis of lectin-carbohydrate recognition

31 March 2020

1 reference

Axis of evil: molecular mechanisms of cancer metastasis

31 March 2020

1 reference

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena

31 March 2020

1 reference

Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans

31 March 2020

1 reference

31 March 2020

1 reference

Mucins in cancer: protection and control of the cell surface

31 March 2020

1 reference

Hyaluronan: from extracellular glue to pericellular cue.

31 March 2020

1 reference

Reversibility of oncogene-induced cancer

31 March 2020

1 reference

Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor

31 March 2020

1 reference

Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.

31 March 2020

1 reference

Molecular diversity of heparan sulfate

31 March 2020

1 reference

Functions of cell surface heparan sulfate proteoglycans

31 March 2020

1 reference

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

31 March 2020

1 reference

Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.

31 March 2020

1 reference

Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition

31 March 2020

1 reference

Glypicans in growth control and cancer

31 March 2020

1 reference

Signaling properties of hyaluronan receptors

31 March 2020

1 reference

Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice

31 March 2020

1 reference

Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan

31 March 2020

1 reference

O-Linked N-Acetylglucosamine and Cancer: Messages from the Glycosylation of C-Myc

31 March 2020

1 reference

Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo

31 March 2020

1 reference

Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1

31 March 2020

1 reference

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

31 March 2020

1 reference

Recombinant antibodies in the immunotherapy of neuroblastoma: perspectives of new developments

31 March 2020

1 reference

Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine

31 March 2020

1 reference

Polyamine metabolism and cancer.

31 March 2020

1 reference

Tumor attenuation by combined heparan sulfate and polyamine depletion.

31 March 2020

1 reference

Inhibition of tumor growth in vivo by hyaluronan oligomers.

31 March 2020

1 reference

UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice

31 March 2020

1 reference

Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis

31 March 2020

1 reference

Cell adhesion system and human cancer morphogenesis

31 March 2020

1 reference

Polysialic acid directs tumor cell growth by controlling heterophilic neural cell adhesion molecule interactions.

31 March 2020

1 reference

Polysialyltransferases: major players in polysialic acid synthesis on the neural cell adhesion molecule

31 March 2020

1 reference

Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells

31 March 2020

1 reference

A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase

31 March 2020

1 reference

Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.

31 March 2020

1 reference

Focal adhesion regulation of cell behavior.

31 March 2020

1 reference

Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions

31 March 2020

1 reference

A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation

31 March 2020

1 reference

Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers

31 March 2020

1 reference

Cooperation of syndecan-2 and syndecan-4 among cell surface heparan sulfate proteoglycans in the actin cytoskeletal organization of Lewis lung carcinoma cells.

31 March 2020

1 reference

Heparan sulfate proteoglycans of Ras-transformed 3T3 or neuroblastoma cells. Differing functions in adhesion on fibronectin

31 March 2020

1 reference

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

31 March 2020

1 reference

Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells

31 March 2020

1 reference

Syndecans in tumor cell adhesion and signaling

31 March 2020

1 reference

The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells

31 March 2020

1 reference

Heparan sulfate proteoglycans in invasion and metastasis

31 March 2020

1 reference

Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion

31 March 2020

1 reference

A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion

31 March 2020

1 reference

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

31 March 2020

1 reference

CD44 is the principal cell surface receptor for hyaluronate

31 March 2020

1 reference

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

31 March 2020

1 reference

Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44. Demonstration of the interaction between rantes and chondroitin sulfate

31 March 2020

1 reference

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

31 March 2020

1 reference

Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis

31 March 2020

1 reference

Molecular properties and involvement of heparanase in cancer progression and normal development

31 March 2020

1 reference

Perlecan and tumor angiogenesis

31 March 2020

1 reference

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

31 March 2020

1 reference

31 March 2020

1 reference

Suppression of tumor growth and metastasis in Mgat5-deficient mice

31 March 2020

1 reference

The joys of HexNAc. The synthesis and function of N- and O-glycan branches

31 March 2020

1 reference

Selective inhibition of polysialyltransferase ST8SiaII by unnatural sialic acids

31 March 2020

1 reference

An expanding role for antithrombotic therapy in cancer patients

31 March 2020

1 reference

Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells

31 March 2020

1 reference

Glycosaminoglycans in human breast cancer

31 March 2020

1 reference

Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells

31 March 2020

1 reference

Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice

31 March 2020

1 reference

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

31 March 2020

1 reference

Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

31 March 2020

1 reference

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

31 March 2020

1 reference

Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties

31 March 2020

1 reference

Heparin derivatives as angiogenesis inhibitors

31 March 2020

1 reference

Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.

31 March 2020

1 reference

Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding

31 March 2020

1 reference

Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.

31 March 2020

1 reference

The role of integrins in tumor angiogenesis

31 March 2020

1 reference

Are selectins involved in metastasis?

31 March 2020

1 reference

Pictures in molecular medicine: three-dimensional visualization of intravascular tumor cells in mice

31 March 2020

1 reference

P-selectin deficiency attenuates tumor growth and metastasis

31 March 2020

1 reference

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

31 March 2020

1 reference

Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis

31 March 2020

1 reference

Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: Sialosyl-Lewis(a), Sialosyl-Lewis(x) and sialosyl-Tn

31 March 2020

1 reference

Involvement of chemokine receptors in breast cancer metastasis

31 March 2020

1 reference

Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.

31 March 2020

1 reference

New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins

31 March 2020

1 reference

Galectins as modulators of tumour progression

31 March 2020

1 reference

Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line

31 March 2020

1 reference

Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis

31 March 2020

1 reference

Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear.

31 March 2020

1 reference

Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors

31 March 2020

1 reference

A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin

31 March 2020

1 reference

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

31 March 2020

1 reference

Arrays for the combinatorial exploration of cell adhesion

31 March 2020

1 reference

Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys.

31 March 2020

1 reference

Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion

31 March 2020

1 reference

L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis

31 March 2020

1 reference

Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma

31 March 2020

1 reference

Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity

31 March 2020

1 reference

Biological therapy of colorectal cancer

31 March 2020

1 reference

Use of surrogate antigens as vaccines against cancer

31 March 2020

1 reference

Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens

31 March 2020

1 reference

Gangliosides inhibit the development from monocytes to dendritic cells

31 March 2020

1 reference

Mechanisms of ganglioside inhibition of APC function

31 March 2020

1 reference

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

31 March 2020

1 reference

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

31 March 2020

1 reference

Difference in prognostic value between sialyl Lewis(a) and sialyl Lewis(x) antigen levels in the preoperative serum of gastric cancer patients

31 March 2020

1 reference

The cancer antigen CA125 represents a novel counter receptor for galectin-1.

31 March 2020

1 reference

Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue

31 March 2020

1 reference

MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion

31 March 2020

1 reference

Expanding the diversity of unnatural cell-surface sialic acids

31 March 2020

1 reference

Cell surface engineering by a modified Staudinger reaction

31 March 2020

1 reference

Targeting glycosylation as a therapeutic approach

31 March 2020

1 reference

Cancer metastasis: a search for therapeutic inhibition

31 March 2020

1 reference

Chemical remodelling of cell surfaces in living animals

31 March 2020

1 reference

Galectin-3 and metastasis

31 March 2020

1 reference

Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells

31 March 2020

1 reference

Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.

31 March 2020

1 reference

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

31 March 2020

1 reference

Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin

31 March 2020

1 reference

Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity.

31 March 2020

1 reference

Targeting PDGF receptors in cancer--rationales and proof of concept clinical trials.

31 March 2020

1 reference

Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC1649

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference